{"data":{"matter":{"matter_id":"mat_5c445c740078a1","slug":"suboxone-tooth-decay","name":"Suboxone Tooth Decay / Dental Injury MDL","category":"mass_tort","subcategory":"pharma","status":"litigated","score":0.74,"score_30d":0.5667,"velocity":0.0482,"headline":"Suboxone tooth decay and dental injury MDL - newly consolidated","summary":"Indivior's Suboxone sublingual films have been alleged to cause severe tooth decay, dental erosion, and tooth loss due to extended oral contact with the medication's acidic compounds. MDL No. 3092 was consolidated in the Northern District of Ohio in 2024. Suboxone is used for opioid use disorder treatment, so plaintiffs are typically long-term medication-assisted treatment patients.","eligibility_hint":"Used Suboxone sublingual films for at least six months and experienced severe tooth decay, dental erosion, or tooth loss","payout":{"band":"mass_tort","low_cents":500000,"high_cents":15000000,"low_usd":5000,"high_usd":150000},"keywords":{"products":["suboxone","buprenorphine","naloxone","sublingual film"],"brands":["indivior","reckitt benckiser"]},"links":{"primary":"https://www.ohnd.uscourts.gov/","self":"https://getclaimscout.com/api/v1/matters/suboxone-tooth-decay","html":"https://getclaimscout.com/matters/suboxone-tooth-decay","lp":null},"lifecycle":{"first_seen_iso":"2026-05-19T11:12:27Z","last_signal_iso":"2026-08-28T18:24:10Z","mdl_filed_iso":null,"settlement_announced_iso":null,"claims_open_iso":null,"claims_close_iso":null,"narrative_generated_iso":"2026-07-07T10:06:25Z"},"attached_cases_count":0,"embedding_model":null,"embedding_version":1,"schema_version":1},"attached_cases":[],"recent_signals":[{"signal_id":"sig_94607304e10dfa","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74716150","kind":"court_filing","title":"CL filing: FUSSELL v. CORECARE BEHAVIORAL HEALTH MANAGEMENT, INC.","summary":"Federal filing in paed, docket 2:26-cv-06420, dated 2026-08-28.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06420","date_filed":"2026-08-28","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-09-01T11:19:00Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-28T18:24:10Z","last_seen_iso":"2026-09-01T11:19:00Z","schema_version":1},{"signal_id":"sig_6b19fd27740c3a","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-P-9803-0008","kind":"regulations_doc","title":"Reference 6","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-9803-0008","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-9803-0008","posted_date":"2026-08-26T04:00:00Z","retrieved_at":"2026-09-01T11:11:18Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-27T17:22:58Z","last_seen_iso":"2026-09-01T11:11:18Z","schema_version":1},{"signal_id":"sig_9a782df6babedb","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-P-9803-0012","kind":"regulations_doc","title":"Reference 10","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-9803-0012","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-9803-0012","posted_date":"2026-08-26T04:00:00Z","retrieved_at":"2026-09-01T11:11:17Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-27T17:22:48Z","last_seen_iso":"2026-09-01T11:11:17Z","schema_version":1},{"signal_id":"sig_6875bebc452d19","matter_id":"mat_5c445c740078a1","source":"google_news","source_id":"gnews:CBMivwFBVV95cUxPVmIyeGxqREpXcEk5QXlCWEJRTkhKcnFwNm1FRUVqSmZXXzJxVlA5YWFpMnBRbGRoMzQxU0lMYVFfOElLWTMzMHRfRDBuRUhrcDRpZlVhMWFNTTVVWnkySmFDbkVKczJBdDN4b2xSdmh5WW5Uc2piaktWQ1JYSGFOSnJISzlpNUhDR21mWl9kRldua19oTXFoRVUzSGVHUTRuUHhaY2lzZHdudnVaVEVkSlliZWJ2SGUzMXhrSkJWNA","kind":"news_article","title":"Suboxone Users Punished for Recovery - LawyersandSettlements.com","summary":"Suboxone Users Punished for Recovery    LawyersandSettlements.com","url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPVmIyeGxqREpXcEk5QXlCWEJRTkhKcnFwNm1FRUVqSmZXXzJxVlA5YWFpMnBRbGRoMzQxU0lMYVFfOElLWTMzMHRfRDBuRUhrcDRpZlVhMWFNTTVVWnkySmFDbkVKczJBdDN4b2xSdmh5WW5Uc2piaktWQ1JYSGFOSnJISzlpNUhDR21mWl9kRldua19oTXFoRVUzSGVHUTRuUHhaY2lzZHdudnVaVEVkSlliZWJ2SGUzMXhrSkJWNA?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"google_news_rss","published":"Tue, 25 Aug 2026 08:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPVmIyeGxqREpXcEk5QXlCWEJRTkhKcnFwNm1FRUVqSmZXXzJxVlA5YWFpMnBRbGRoMzQxU0lMYVFfOElLWTMzMHRfRDBuRUhrcDRpZlVhMWFNTTVVWnkySmFDbkVKczJBdDN4b2xSdmh5WW5Uc2piaktWQ1JYSGFOSnJISzlpNUhDR21mWl9kRldua19oTXFoRVUzSGVHUTRuUHhaY2lzZHdudnVaVEVkSlliZWJ2SGUzMXhrSkJWNA?oc=5","retrieved_at":"2026-09-01T11:10:08Z","search_query":"\"suboxone\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.875,"first_seen_iso":"2026-08-26T06:46:42Z","last_seen_iso":"2026-09-01T11:10:08Z","schema_version":1},{"signal_id":"sig_c35c3a23bc2ac0","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73607410","kind":"court_filing","title":"CL filing: Carter v. The South Dakota State Penitentiary","summary":"Federal filing in sdd, docket 4:26-cv-04124, dated 2026-07-10.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"sdd","docket_no":"4:26-cv-04124","date_filed":"2026-07-10","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-09-01T11:19:01Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-25T06:52:06Z","last_seen_iso":"2026-09-01T11:19:01Z","schema_version":1},{"signal_id":"sig_35de02782b3e7e","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2007-D-0369-2640","kind":"regulations_doc","title":"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","summary":"Notice of Availability","url":"https://www.regulations.gov/document/FDA-2007-D-0369-2640","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Notice","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2007-D-0369-2640","posted_date":"2026-08-24T04:00:00Z","retrieved_at":"2026-09-01T11:11:18Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-25T06:44:48Z","last_seen_iso":"2026-09-01T11:11:18Z","schema_version":1},{"signal_id":"sig_2f1ac4127c5e23","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2007-D-0369-2653","kind":"regulations_doc","title":"PSG_020732 - Draft Guidance on Buprenorphine","summary":"Guidance","url":"https://www.regulations.gov/document/FDA-2007-D-0369-2653","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Other","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2007-D-0369-2653","posted_date":"2026-08-24T04:00:00Z","retrieved_at":"2026-09-01T11:11:18Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-25T06:44:48Z","last_seen_iso":"2026-09-01T11:11:18Z","schema_version":1},{"signal_id":"sig_7bb64d29b7033d","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73546485","kind":"court_filing","title":"CL filing: Branch v. Fabor","summary":"Federal filing in vawd, docket 7:26-cv-00515, dated 2026-06-26.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"vawd","docket_no":"7:26-cv-00515","date_filed":"2026-06-26","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-08-31T12:58:25Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-19T06:51:16Z","last_seen_iso":"2026-08-31T12:58:25Z","schema_version":1},{"signal_id":"sig_08156066360921","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-P-9352-0015","kind":"regulations_doc","title":"Reference 13 - NCTR 4-5-2023 final","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-9352-0015","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-9352-0015","posted_date":"2026-08-18T04:00:00Z","retrieved_at":"2026-09-01T11:11:18Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-19T06:42:42Z","last_seen_iso":"2026-09-01T11:11:18Z","schema_version":1},{"signal_id":"sig_2efb62206efe6c","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73600111","kind":"court_filing","title":"CL filing: M.C. v. American Addiction Centers, Inc.","summary":"Federal filing in nvd, docket 2:26-cv-02089, dated 2026-07-10.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"nvd","docket_no":"2:26-cv-02089","date_filed":"2026-07-10","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-09-01T11:19:01Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-14T07:31:14Z","last_seen_iso":"2026-09-01T11:19:01Z","schema_version":1},{"signal_id":"sig_b59e1e86f34a2a","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73550877","kind":"court_filing","title":"CL filing: United States v. Betancourt","summary":"Federal filing in cacd, docket 2:26-cr-00404, dated 2026-06-23.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"cacd","docket_no":"2:26-cr-00404","date_filed":"2026-06-23","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-08-27T17:32:00Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-08T06:59:53Z","last_seen_iso":"2026-08-27T17:32:00Z","schema_version":1},{"signal_id":"sig_9964cd6aea53c1","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73550872","kind":"court_filing","title":"CL filing: United States v. Betancourt","summary":"Federal filing in cacd, docket 2:26-cr-00404, dated 2026-06-23.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"cacd","docket_no":"2:26-cr-00404","date_filed":"2026-06-23","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-08-24T07:05:06Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-08T06:59:53Z","last_seen_iso":"2026-08-24T07:05:06Z","schema_version":1},{"signal_id":"sig_192144e485a756","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73682667","kind":"court_filing","title":"CL filing: Cole v. Knaack","summary":"Federal filing in miwd, docket 1:26-cv-02184, dated 2026-07-27.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"miwd","docket_no":"1:26-cv-02184","date_filed":"2026-07-27","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-09-01T11:19:00Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:44:04Z","last_seen_iso":"2026-09-01T11:19:00Z","schema_version":1},{"signal_id":"sig_50294e423de34e","matter_id":"mat_5c445c740078a1","source":"fda_faers","source_id":"faers:26944453","kind":"adverse_event_report","title":"FAERS: suboxone - Carditis, Gingival abscess, Cellulitis, Tooth infection, Off label use","summary":"FDA Adverse Event Report ID 26944453. Reactions: Carditis, Gingival abscess, Cellulitis, Tooth infection, Off label use. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26944453","score":0.85,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Carditis","Gingival abscess","Cellulitis","Tooth infection","Off label use","Tooth erosion"],"drug_query":"suboxone","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26944453","receivedate":"20260630","retrieved_at":"2026-09-01T11:12:02Z","safetyreportid":"26944453"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:37:18Z","last_seen_iso":"2026-09-01T11:12:02Z","schema_version":1},{"signal_id":"sig_e1cf47b61af311","matter_id":"mat_5c445c740078a1","source":"fda_faers","source_id":"faers:26947335","kind":"adverse_event_report","title":"FAERS: suboxone - Carpal tunnel decompression, Illness, Injection site pain, Nausea, Pruritus","summary":"FDA Adverse Event Report ID 26947335. Reactions: Carpal tunnel decompression, Illness, Injection site pain, Nausea, Pruritus. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26947335","score":0.85,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Carpal tunnel decompression","Illness","Injection site pain","Nausea","Pruritus","Product dose omission issue"],"drug_query":"suboxone","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26947335","receivedate":"20260630","retrieved_at":"2026-09-01T11:12:02Z","safetyreportid":"26947335"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:37:18Z","last_seen_iso":"2026-09-01T11:12:02Z","schema_version":1},{"signal_id":"sig_14f389d881e964","matter_id":"mat_5c445c740078a1","source":"fda_faers","source_id":"faers:26912672","kind":"adverse_event_report","title":"FAERS: suboxone - Breast cancer stage IV","summary":"FDA Adverse Event Report ID 26912672. Reactions: Breast cancer stage IV. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26912672","score":0.85,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Breast cancer stage IV"],"drug_query":"suboxone","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26912672","receivedate":"20260623","retrieved_at":"2026-09-01T11:12:03Z","safetyreportid":"26912672"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:37:18Z","last_seen_iso":"2026-09-01T11:12:03Z","schema_version":1},{"signal_id":"sig_93b55c3efea850","matter_id":"mat_5c445c740078a1","source":"fda_faers","source_id":"faers:26912987","kind":"adverse_event_report","title":"FAERS: suboxone - Presyncope, Cholecystitis, Cholecystectomy, Therapy cessation","summary":"FDA Adverse Event Report ID 26912987. Reactions: Presyncope, Cholecystitis, Cholecystectomy, Therapy cessation. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26912987","score":0.85,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Presyncope","Cholecystitis","Cholecystectomy","Therapy cessation"],"drug_query":"suboxone","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26912987","receivedate":"20260622","retrieved_at":"2026-09-01T11:12:03Z","safetyreportid":"26912987"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:37:18Z","last_seen_iso":"2026-09-01T11:12:03Z","schema_version":1},{"signal_id":"sig_d6cf0575a922b6","matter_id":"mat_5c445c740078a1","source":"fda_faers","source_id":"faers:26927865","kind":"adverse_event_report","title":"FAERS: suboxone - Myelopathy, Rhabdomyolysis, Substance abuse, Unresponsive to stimuli, Quadriparesis","summary":"FDA Adverse Event Report ID 26927865. Reactions: Myelopathy, Rhabdomyolysis, Substance abuse, Unresponsive to stimuli, Quadriparesis. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26927865","score":0.85,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Myelopathy","Rhabdomyolysis","Substance abuse","Unresponsive to stimuli","Quadriparesis","Spinal vascular disorder","Compartment syndrome","Hyponatraemia"],"drug_query":"suboxone","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26927865","receivedate":"20260626","retrieved_at":"2026-09-01T11:12:03Z","safetyreportid":"26927865"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:37:18Z","last_seen_iso":"2026-09-01T11:12:03Z","schema_version":1},{"signal_id":"sig_aca7168c6d7ad4","matter_id":"mat_5c445c740078a1","source":"fda_faers","source_id":"faers:26913561","kind":"adverse_event_report","title":"FAERS: suboxone - Transcription medication error, Treatment noncompliance, Wrong product administered, Circumstance or information capable","summary":"FDA Adverse Event Report ID 26913561. Reactions: Transcription medication error, Treatment noncompliance, Wrong product administered, Circumstance or information capable of leading to medication error. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26913561","score":0.85,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Transcription medication error","Treatment noncompliance","Wrong product administered","Circumstance or information capable of leading to medication error"],"drug_query":"suboxone","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26913561","receivedate":"20260623","retrieved_at":"2026-09-01T11:12:03Z","safetyreportid":"26913561"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:37:18Z","last_seen_iso":"2026-09-01T11:12:03Z","schema_version":1},{"signal_id":"sig_8c51da0d918340","matter_id":"mat_5c445c740078a1","source":"fda_faers","source_id":"faers:26931319","kind":"adverse_event_report","title":"FAERS: suboxone - Rhabdomyolysis, Spinal vascular disorder, Toxicity to various agents, Intentional product use issue","summary":"FDA Adverse Event Report ID 26931319. Reactions: Rhabdomyolysis, Spinal vascular disorder, Toxicity to various agents, Intentional product use issue. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26931319","score":0.85,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Rhabdomyolysis","Spinal vascular disorder","Toxicity to various agents","Intentional product use issue"],"drug_query":"suboxone","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26931319","receivedate":"20260628","retrieved_at":"2026-09-01T11:12:03Z","safetyreportid":"26931319"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:37:18Z","last_seen_iso":"2026-09-01T11:12:03Z","schema_version":1},{"signal_id":"sig_8858a5f6c179c4","matter_id":"mat_5c445c740078a1","source":"fda_faers","source_id":"faers:26922045","kind":"adverse_event_report","title":"FAERS: suboxone - Accidental overdose, Toxicity to various agents","summary":"FDA Adverse Event Report ID 26922045. Reactions: Accidental overdose, Toxicity to various agents. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26922045","score":0.85,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Accidental overdose","Toxicity to various agents"],"drug_query":"suboxone","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26922045","receivedate":"20260625","retrieved_at":"2026-09-01T11:12:03Z","safetyreportid":"26922045"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-04T08:37:18Z","last_seen_iso":"2026-09-01T11:12:03Z","schema_version":1},{"signal_id":"sig_e4782a84a37b67","matter_id":"mat_5c445c740078a1","source":"google_news","source_id":"gnews:CBMioAFBVV95cUxPcldxc2szcUkwMzlscm5SMnp5bEs5SFhTa09pcG9ZbmxyN0pxMjMxWTM1ZUZORThLMDJTYUFjbkM3NFh6VEF0c1pEbDFQZ3FsejNWUWtXTUx3N0MtdjhodDhNdGQzQ3BFNl9jNlZrSWpldXlrdXNhaWR6V0djdUI2WXdsWUZYbmhIcmhidTc4SEo2b3dLWWNfV0dFTC0wUnB5","kind":"news_article","title":"Does Suboxone Cause Tooth Decay? [2026 Update] - robertkinglawfirm.com","summary":"Does Suboxone Cause Tooth Decay? [2026 Update]    robertkinglawfirm.com","url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPcldxc2szcUkwMzlscm5SMnp5bEs5SFhTa09pcG9ZbmxyN0pxMjMxWTM1ZUZORThLMDJTYUFjbkM3NFh6VEF0c1pEbDFQZ3FsejNWUWtXTUx3N0MtdjhodDhNdGQzQ3BFNl9jNlZrSWpldXlrdXNhaWR6V0djdUI2WXdsWUZYbmhIcmhidTc4SEo2b3dLWWNfV0dFTC0wUnB5?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"google_news_rss","published":"Mon, 20 Jul 2026 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPcldxc2szcUkwMzlscm5SMnp5bEs5SFhTa09pcG9ZbmxyN0pxMjMxWTM1ZUZORThLMDJTYUFjbkM3NFh6VEF0c1pEbDFQZ3FsejNWUWtXTUx3N0MtdjhodDhNdGQzQ3BFNl9jNlZrSWpldXlrdXNhaWR6V0djdUI2WXdsWUZYbmhIcmhidTc4SEo2b3dLWWNfV0dFTC0wUnB5?oc=5","retrieved_at":"2026-08-25T06:43:37Z","search_query":"\"suboxone\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.925,"first_seen_iso":"2026-08-02T08:23:01Z","last_seen_iso":"2026-08-25T06:43:37Z","schema_version":1},{"signal_id":"sig_d20ae300fc4a99","matter_id":"mat_5c445c740078a1","source":"google_news","source_id":"gnews:CBMinAFBVV95cUxNZ3h1S0pBakQ0aXZYaUpyTkFtb3ZWWjhtVjVhcW4tQkg0TE4wUENmbnNJZDVZUUxTOWliTWlXNlAyM29MWVJXa1FaSnpPVFZpZU9OZTBnMWNZZndWb2tSem53RWJHeGFvNkxFV25kczZsLUR0Qy05RFZQY0tyZHE4Z0lzLXpiNi1oeEFHczRKQkFadUNjQ1Q0V0UyS0Y","kind":"news_article","title":"Indivior To Pay $300M To Settle Suboxone Opioid Marketing Claims By DOJ, States - AboutLawsuits.com","summary":"Indivior To Pay $300M To Settle Suboxone Opioid Marketing Claims By DOJ, States    AboutLawsuits.com","url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNZ3h1S0pBakQ0aXZYaUpyTkFtb3ZWWjhtVjVhcW4tQkg0TE4wUENmbnNJZDVZUUxTOWliTWlXNlAyM29MWVJXa1FaSnpPVFZpZU9OZTBnMWNZZndWb2tSem53RWJHeGFvNkxFV25kczZsLUR0Qy05RFZQY0tyZHE4Z0lzLXpiNi1oeEFHczRKQkFadUNjQ1Q0V0UyS0Y?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"google_news_rss","published":"Wed, 29 Jul 2026 14:02:17 GMT","source_url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNZ3h1S0pBakQ0aXZYaUpyTkFtb3ZWWjhtVjVhcW4tQkg0TE4wUENmbnNJZDVZUUxTOWliTWlXNlAyM29MWVJXa1FaSnpPVFZpZU9OZTBnMWNZZndWb2tSem53RWJHeGFvNkxFV25kczZsLUR0Qy05RFZQY0tyZHE4Z0lzLXpiNi1oeEFHczRKQkFadUNjQ1Q0V0UyS0Y?oc=5","retrieved_at":"2026-07-31T08:48:25Z","search_query":"\"suboxone\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.875,"first_seen_iso":"2026-07-31T08:48:25Z","last_seen_iso":"2026-07-31T08:48:25Z","schema_version":1},{"signal_id":"sig_2c9e2e57b86bae","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73493081","kind":"court_filing","title":"CL filing: Latimore v. Advanced Recovery Systems LLC","summary":"Federal filing in flsd, docket 0:26-cv-61714, dated 2026-06-16.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"flsd","docket_no":"0:26-cv-61714","date_filed":"2026-06-16","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-08-13T07:33:13Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-30T08:35:01Z","last_seen_iso":"2026-08-13T07:33:13Z","schema_version":1},{"signal_id":"sig_93b3dec6786cd1","matter_id":"mat_5c445c740078a1","source":"google_news","source_id":"gnews:CBMiygFBVV95cUxOUHhTY1JWLXdlMmhHenYwMWFZVUY5YmdSVjdIR0p0bkozeHNiRGROX1c2c09NdHE0bzVQSUxRa2Z5RVhNUG9VQ0VOUjJyWmxwTnNPRFBQRWRkMlBHMUd0WTlOWURRX1hKNzlyVE03aXRmRHZaTEMzdFphZlU1R09lYTVQUGVON1RHaDZaYXJQZ1I4V1l2OUtsRzhGSFRTcEFRM3Q1TXlFSkVWRld2NUlHOTZHdFEwRG1RcWdOYW9nRm93ZWU0RjE1cEtB","kind":"news_article","title":"Suboxone Lawsuit Cites Safer Alternative - LawyersandSettlements.com","summary":"Suboxone Lawsuit Cites Safer Alternative    LawyersandSettlements.com","url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOUHhTY1JWLXdlMmhHenYwMWFZVUY5YmdSVjdIR0p0bkozeHNiRGROX1c2c09NdHE0bzVQSUxRa2Z5RVhNUG9VQ0VOUjJyWmxwTnNPRFBQRWRkMlBHMUd0WTlOWURRX1hKNzlyVE03aXRmRHZaTEMzdFphZlU1R09lYTVQUGVON1RHaDZaYXJQZ1I4V1l2OUtsRzhGSFRTcEFRM3Q1TXlFSkVWRld2NUlHOTZHdFEwRG1RcWdOYW9nRm93ZWU0RjE1cEtB?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"google_news_rss","published":"Wed, 29 Jul 2026 11:15:00 GMT","source_url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOUHhTY1JWLXdlMmhHenYwMWFZVUY5YmdSVjdIR0p0bkozeHNiRGROX1c2c09NdHE0bzVQSUxRa2Z5RVhNUG9VQ0VOUjJyWmxwTnNPRFBQRWRkMlBHMUd0WTlOWURRX1hKNzlyVE03aXRmRHZaTEMzdFphZlU1R09lYTVQUGVON1RHaDZaYXJQZ1I4V1l2OUtsRzhGSFRTcEFRM3Q1TXlFSkVWRld2NUlHOTZHdFEwRG1RcWdOYW9nRm93ZWU0RjE1cEtB?oc=5","retrieved_at":"2026-08-13T07:25:12Z","search_query":"\"suboxone\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.875,"first_seen_iso":"2026-07-30T08:25:20Z","last_seen_iso":"2026-08-13T07:25:12Z","schema_version":1}]},"meta":{"api_version":"v1","schema_version":1,"self":"https://getclaimscout.com/api/v1/matters/suboxone-tooth-decay","docs":"https://getclaimscout.com/openapi.json","llms_txt":"https://getclaimscout.com/llms.txt"}}